A Regulatory Feedback between Plasmacytoid Dendritic Cells and Regulatory B Cells Is Aberrant in Systemic Lupus Erythematosus

Immunity

Volumn 44, Issue 3, 2016, Pages 683-697

  Menon, Madhvi ^a   Blair, Paul A ^a   Isenberg, David A ^a   Mauri, Claudia ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; CD19 ANTIGEN; CD24 ANTIGEN; CD38 ANTIGEN; CD40 ANTIGEN; INTERLEUKIN 10; RITUXIMAB; STAT1 PROTEIN; STAT3 PROTEIN; ANTIRHEUMATIC AGENT; GAMMA INTERFERON; LEUKOCYTE ANTIGEN;

ARTICLE; B LYMPHOCYTE; B LYMPHOCYTE DIFFERENTIATION; CELL EXPANSION; CELL INTERACTION; CELL MIGRATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; FEEDBACK SYSTEM; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LYMPHOCYTE COUNT; PATHOGENESIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PLASMA CELL; PLASMABLAST; PLASMACYTOID DENDRITIC CELL; PRIORITY JOURNAL; PROTEIN FUNCTION; RECEPTOR UPREGULATION; SYSTEMIC LUPUS ERYTHEMATOSUS; TREATMENT RESPONSE; ADULT; AGED; CELL COMMUNICATION; CELL CULTURE; CELL DIFFERENTIATION; DENDRITIC CELL; DRUG EFFECTS; FEMALE; HOMEOSTASIS; IMMUNOLOGY; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; METABOLISM; MIDDLE AGED; TRANSCRIPTION INITIATION; YOUNG ADULT;

ADULT; AGED; ANTIGENS, CD; ANTIRHEUMATIC AGENTS; B-LYMPHOCYTES, REGULATORY; CELL COMMUNICATION; CELL DIFFERENTIATION; CELLS, CULTURED; DENDRITIC CELLS; FEMALE; HOMEOSTASIS; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-10; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; RITUXIMAB; STAT1 TRANSCRIPTION FACTOR; STAT3 TRANSCRIPTION FACTOR; TRANSCRIPTIONAL ACTIVATION; YOUNG ADULT;

EID: 84960435612     PISSN: 10747613     EISSN: 10974180     Source Type: Journal    
DOI: 10.1016/j.immuni.2016.02.012     Document Type: Article

References (55)

1. Anolik J.H., Barnard J., Owen T., Zheng B., Kemshetti S., Looney R.J., Sanz I. Delayed memory B cell recovery in peripheral blood and lymphoid tissue in systemic lupus erythematosus after B cell depletion therapy. Arthritis Rheum. 2007, 56:3044-3056.
2. Baccala R., Gonzalez-Quintial R., Schreiber R.D., Lawson B.R., Kono D.H., Theofilopoulos A.N. Anti-IFN-α/β receptor antibody treatment ameliorates disease in lupus-predisposed mice. J. Immunol. 2012, 189:5976-5984.
3. Baccala R., Gonzalez-Quintial R., Blasius A.L., Rimann I., Ozato K., Kono D.H., Beutler B., Theofilopoulos A.N. Essential requirement for IRF8 and SLC15A4 implicates plasmacytoid dendritic cells in the pathogenesis of lupus. Proc. Natl. Acad. Sci. USA 2013, 110:2940-2945.
4. Benkhart E.M., Siedlar M., Wedel A., Werner T., Ziegler-Heitbrock H.W. Role of Stat3 in lipopolysaccharide-induced IL-10 gene expression. J. Immunol. 2000, 165:1612-1617.
5. Bennett L., Palucka A.K., Arce E., Cantrell V., Borvak J., Banchereau J., Pascual V. Interferon and granulopoiesis signatures in systemic lupus erythematosus blood. J. Exp. Med. 2003, 197:711-723.
6. Blair P.A., Noreña L.Y., Flores-Borja F., Rawlings D.J., Isenberg D.A., Ehrenstein M.R., Mauri C. CD19(+)CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic Lupus Erythematosus patients. Immunity 2010, 32:129-140.
7. Blanco P., Palucka A.K., Gill M., Pascual V., Banchereau J. Induction of dendritic cell differentiation by IFN-alpha in systemic lupus erythematosus. Science 2001, 294:1540-1543.
8. Bosma A., Abdel-Gadir A., Isenberg D.A., Jury E.C., Mauri C. Lipid-antigen presentation by CD1d(+) B cells is essential for the maintenance of invariant natural killer T cells. Immunity 2012, 36:477-490.
9. Cederblad B., Blomberg S., Vallin H., Perers A., Alm G.V., Rönnblom L. Patients with systemic lupus erythematosus have reduced numbers of circulating natural interferon-alpha- producing cells. J. Autoimmun. 1998, 11:465-470.
10. Duramad O., Fearon K.L., Chan J.H., Kanzler H., Marshall J.D., Coffman R.L., Barrat F.J. IL-10 regulates plasmacytoid dendritic cell response to CpG-containing immunostimulatory sequences. Blood 2003, 102:4487-4492.
11. Feng X., Wu H., Grossman J.M., Hanvivadhanakul P., FitzGerald J.D., Park G.S., Dong X., Chen W., Kim M.H., Weng H.H., et al. Association of increased interferon-inducible gene expression with disease activity and lupus nephritis in patients with systemic lupus erythematosus. Arthritis Rheum. 2006, 54:2951-2962.
12. Flores-Borja F., Bosma A., Ng D., Reddy V., Ehrenstein M.R., Isenberg D.A., Mauri C. CD19+CD24hiCD38hi B cells maintain regulatory T cells while limiting TH1 and TH17 differentiation. Sci. Transl. Med. 2013, 5:173ra23.
13. Francisco L.M., Salinas V.H., Brown K.E., Vanguri V.K., Freeman G.J., Kuchroo V.K., Sharpe A.H. PD-L1 regulates the development, maintenance, and function of induced regulatory T cells. J. Exp. Med. 2009, 206:3015-3029.
14. Frisullo G., Calabrese M., Tortorella C., Paolicelli D., Ragonese P., Annovazzi P., Radaelli M., Malucchi S., Gallo A., Tomassini V., et al. Thyroid autoimmunity and dysfunction in multiple sclerosis patients during long-term treatment with interferon beta or glatiramer acetate: an Italian multicenter study. Mult. Scler. 2014, 20:1265-1268.
15. Garcia-Romo G.S., Caielli S., Vega B., Connolly J., Allantaz F., Xu Z., Punaro M., Baisch J., Guiducci C., Coffman R.L., et al. Netting neutrophils are major inducers of type I IFN production in pediatric systemic lupus erythematosus. Sci. Transl. Med. 2011, 3:73ra20.
16. Georg P., Bekeredjian-Ding I. Plasmacytoid dendritic cells control B cell-derived IL-10 production. Autoimmunity 2012, 45:579-583.
17. Gilliet M., Cao W., Liu Y.J. Plasmacytoid dendritic cells: sensing nucleic acids in viral infection and autoimmune diseases. Nat. Rev. Immunol. 2008, 8:594-606.
18. Hartmann G., Battiany J., Poeck H., Wagner M., Kerkmann M., Lubenow N., Rothenfusser S., Endres S. Rational design of new CpG oligonucleotides that combine B cell activation with high IFN-alpha induction in plasmacytoid dendritic cells. Eur. J. Immunol. 2003, 33:1633-1641.
19. Hoffmann H.H., Schneider W.M., Rice C.M. Interferons and viruses: an evolutionary arms race of molecular interactions. Trends Immunol. 2015, 36:124-138.
20. Honda K., Yanai H., Negishi H., Asagiri M., Sato M., Mizutani T., Shimada N., Ohba Y., Takaoka A., Yoshida N., Taniguchi T. IRF-7 is the master regulator of type-I interferon-dependent immune responses. Nature 2005, 434:772-777.
21. Ito T., Yang M., Wang Y.H., Lande R., Gregorio J., Perng O.A., Qin X.F., Liu Y.J., Gilliet M. Plasmacytoid dendritic cells prime IL-10-producing T regulatory cells by inducible costimulator ligand. J. Exp. Med. 2007, 204:105-115.
22. Ivashkiv L.B., Donlin L.T. Regulation of type I interferon responses. Nat. Rev. Immunol. 2014, 14:36-49.
23. Jego G., Palucka A.K., Blanck J.P., Chalouni C., Pascual V., Banchereau J. Plasmacytoid dendritic cells induce plasma cell differentiation through type I interferon and interleukin 6. Immunity 2003, 19:225-234.
24. Kerkmann M., Rothenfusser S., Hornung V., Towarowski A., Wagner M., Sarris A., Giese T., Endres S., Hartmann G. Activation with CpG-A and CpG-B oligonucleotides reveals two distinct regulatory pathways of type I IFN synthesis in human plasmacytoid dendritic cells. J. Immunol. 2003, 170:4465-4474.
25. Lande R., Ganguly D., Facchinetti V., Frasca L., Conrad C., Gregorio J., Meller S., Chamilos G., Sebasigari R., Riccieri V., et al. Neutrophils activate plasmacytoid dendritic cells by releasing self-DNA-peptide complexes in systemic lupus erythematosus. Sci. Transl. Med. 2011, 3:73ra19.
26. Leandro M.J., Cambridge G., Ehrenstein M.R., Edwards J.C. Reconstitution of peripheral blood B cells after depletion with rituximab in patients with rheumatoid arthritis. Arthritis Rheum. 2006, 54:613-620.
27. Lechmann M., Berchtold S., Hauber J., Steinkasserer A. CD83 on dendritic cells: more than just a marker for maturation. Trends Immunol. 2002, 23:273-275.
28. Li H., Fu Y.-X., Wu Q., Zhou Y., Crossman D.K., Yang P., Li J., Lao B., Morel L.M., Kabarowski J.H., et al. Interferon-induced mechanosensing defects impede apoptotic cell clearance in lupus. J. Clin. Invest. 2015, 125:2877-2890.
29. Luu K., Greenhill C.J., Majoros A., Decker T., Jenkins B.J., Mansell A. STAT1 plays a role in TLR signal transduction and inflammatory responses. Immunol. Cell Biol. 2014, 92:761-769.
30. Malaspina A., Moir S., Ho J., Wang W., Howell M.L., O'Shea M.A., Roby G.A., Rehm C.A., Mican J.M., Chun T.W., Fauci A.S. Appearance of immature/transitional B cells in HIV-infected individuals with advanced disease: correlation with increased IL-7. Proc. Natl. Acad. Sci. USA 2006, 103:2262-2267.
31. Matsumoto M., Baba A., Yokota T., Nishikawa H., Ohkawa Y., Kayama H., Kallies A., Nutt S.L., Sakaguchi S., Takeda K., et al. Interleukin-10-producing plasmablasts exert regulatory function in autoimmune inflammation. Immunity 2014, 41:1040-1051.
32. Mauri C., Bosma A. Immune regulatory function of B cells. Annu. Rev. Immunol. 2012, 30:221-241.
33. Mauri C., Nistala K. Interleukin-35 takes the 'B' line. Nat. Med. 2014, 20:580-581.
34. McKenna K., Beignon A.S., Bhardwaj N. Plasmacytoid dendritic cells: linking innate and adaptive immunity. J. Virol. 2005, 79:17-27.
35. Moseman E.A., Liang X., Dawson A.J., Panoskaltsis-Mortari A., Krieg A.M., Liu Y.J., Blazar B.R., Chen W. Human plasmacytoid dendritic cells activated by CpG oligodeoxynucleotides induce the generation of CD4+CD25+ regulatory T cells. J. Immunol. 2004, 173:4433-4442.
36. Obermoser G., Pascual V. The interferon-alpha signature of systemic lupus erythematosus. Lupus 2010, 19:1012-1019.
37. Pascual V., Farkas L., Banchereau J. Systemic lupus erythematosus: all roads lead to type I interferons. Curr. Opin. Immunol. 2006, 18:676-682.
38. Poeck H., Wagner M., Battiany J., Rothenfusser S., Wellisch D., Hornung V., Jahrsdorfer B., Giese T., Endres S., Hartmann G. Plasmacytoid dendritic cells, antigen, and CpG-C license human B cells for plasma cell differentiation and immunoglobulin production in the absence of T-cell help. Blood 2004, 103:3058-3064.
39. Reizis B., Bunin A., Ghosh H.S., Lewis K.L., Sisirak V. Plasmacytoid dendritic cells: recent progress and open questions. Annu. Rev. Immunol. 2011, 29:163-183.
40. Rivero S.J., Díaz-Jouanen E., Alarcón-Segovia D. Lymphopenia in systemic lupus erythematosus. Clinical, diagnostic, and prognostic significance. Arthritis Rheum. 1978, 21:295-305.
41. Rönnblom L., Eloranta M.L. The interferon signature in autoimmune diseases. Curr. Opin. Rheumatol. 2013, 25:248-253.
42. Rosser E.C., Blair P.A., Mauri C. Cellular targets of regulatory B cell-mediated suppression. Mol. Immunol. 2014, 62:296-304.
43. Rowland S.L., Riggs J.M., Gilfillan S., Bugatti M., Vermi W., Kolbeck R., Unanue E.R., Sanjuan M.A., Colonna M. Early, transient depletion of plasmacytoid dendritic cells ameliorates autoimmunity in a lupus model. J. Exp. Med. 2014, 211:1977-1991.
44. Schubert R.D., Hu Y., Kumar G., Szeto S., Abraham P., Winderl J., Guthridge J.M., Pardo G., Dunn J., Steinman L., Axtell R.C. IFN-β treatment requires B cells for efficacy in neuroautoimmunity. J. Immunol. 2015, 194:2110-2116.
45. Shibuya H., Hirohata S. Differential effects of IFN-alpha on the expression of various TH2 cytokines in human CD4+ T cells. J. Allergy Clin. Immunol. 2005, 116:205-212.
46. Siegal F.P., Kadowaki N., Shodell M., Fitzgerald-Bocarsly P.A., Shah K., Ho S., Antonenko S., Liu Y.J. The nature of the principal type 1 interferon-producing cells in human blood. Science 1999, 284:1835-1837.
47. + T cell function in vitro. J. Leukoc. Biol. 2013, 93:811-818.
48. Sisirak V., Ganguly D., Lewis K.L., Couillault C., Tanaka L., Bolland S., D'Agati V., Elkon K.B., Reizis B. Genetic evidence for the role of plasmacytoid dendritic cells in systemic lupus erythematosus. J. Exp. Med. 2014, 211:1969-1976.
49. Swiecki M., Colonna M. The multifaceted biology of plasmacytoid dendritic cells. Nat. Rev. Immunol. 2015, 15:471-485.
50. Thibault D.L., Chu A.D., Graham K.L., Balboni I., Lee L.Y., Kohlmoos C., Landrigan A., Higgins J.P., Tibshirani R., Utz P.J. IRF9 and STAT1 are required for IgG autoantibody production and B cell expression of TLR7 in mice. J. Clin. Invest. 2008, 118:1417-1426.
51. Tóthová E. [New views on the treatment of chronic myelocytic leukemia. Literature review]. Vnitr. Lek. 2002, 48:230-233.
52. Verweij C.L., Vosslamber S. Relevance of the type I interferon signature in multiple sclerosis towards a personalized medicine approach for interferon-beta therapy. Discov. Med. 2013, 15:51-60.
53. Wilson L.E., Widman D., Dikman S.H., Gorevic P.D. Autoimmune disease complicating antiviral therapy for hepatitis C virus infection. Semin. Arthritis Rheum. 2002, 32:163-173.
54. Yoshizaki A., Miyagaki T., DiLillo D.J., Matsushita T., Horikawa M., Kountikov E.I., Spolski R., Poe J.C., Leonard W.J., Tedder T.F. Regulatory B cells control T-cell autoimmunity through IL-21-dependent cognate interactions. Nature 2012, 491:264-268.
55. Zhang X., Deriaud E., Jiao X., Braun D., Leclerc C., Lo-Man R. Type I interferons protect neonates from acute inflammation through interleukin 10-producing B cells. J. Exp. Med. 2007, 204:1107-1118.